... difference ( p > 0.05). Conclusions: Biofeedback electrical stimulation combined with pelvic floor muscle training is an efficient nonsurgical combination therapy for the symptoms of SUI after HoLEP for benign prostatic hyperplasia. In addition, the recovery of the patient’s psychological state does...

...Hua Luo; Gaoyuan Liao; Xiaobo Wang; Chao He; Yanghan Liu Introduction: Benign prostatic hyperplasia (BPH) is a common condition in older men, marked by the noncancerous enlargement of the prostate gland. Inflammation of the prostate plays a significant role in the progression of BPH...

... data of 548 patients who underwent HoLEP were retrospectively analyzed. The patients were followed up for the occurrence of urinary incontinence in the short term (2 weeks), medium term (3 months), and long term (6 months) after HoLEP. Results: Among the 548 benign prostatic hyperplasia patients, 79...

...Jianping Liu; Weijian Zhou; Peng Zhang; Wei Zhang; Congwang Chang; Guanghua Fu Background: There is limited research into the efficacy and safety of tadalafil combined with tamsulosin for the treatment of lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH...

...Fabio Crocerossa; Francesco Cantiello; Lorenzo Bagalá; Francesco Sicoli; Umberto Carbonara; Celeste Manfredi; Ugo Falagario; Alessandro Veccia; Savio D. Pandolfo; Luigi Napolitano; Matteo Ferro; Michele Di Dio; Nicola Mondaini; Rocco Damiano Introduction: Benign prostatic hyperplasia (BPH...

... symptoms. We assessed its safety, efficacy and impact on urinary flow, ejaculation, and quality of life. Materials and Methods: We included 64 men, treated for benign prostate hyperplasia for at least 1 year. All patients had Qmax≤ 13 mL/s and IPSS >12. Insertion of the device was performed via...

...Atanas Ivanov; Petar Antonov; Eleonora Hristova-Atanasova; Petar Uchikov Introduction: Benign prostatic hyperplasia (BPH) is a histological diagnosis characterized by an increase in the number of epithelial and stromal cells in the transitional zone of the prostate gland. The clinical manifestation...

...Fulin Zhang; Jinbin Xu; Ciming Sun; Fuyang Dai; Qin Zhu; Hui Liang Background: Benign prostatic hyperplasia (BPH) is a common urological disorder leading to dysuria in middle-aged and elderly men and significantly reduces the quality of life of patients. Technology for BPH has made a great progress...

... surgery on EF is of importance [7]. Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) are very common clinical complaints among older men [1]. In fact, the prevalence of BPH is approximately 50% for men in their fifties and reaches up to 80% for men over 80 years...

...Diaa-Eldin Taha; Ali Ibrahim; Mona Talaat; Tarek Abdelbaky; Hossam Nabeeh Objectives: The aim of this study was to assess whether the duration of preoperative benign prostatic hyperplasia (BPH) medication would affect the pressure flow study (PFS) parameters and the outcome of prostate surgery...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate Benign prostatic hyperplasia Holmium laser enucleation...

.... Magnetic resonance imaging Transrectal ultrasound Benign prostatic hyperplasia Digital rectal examination Prostate-specific antigen Prostate volume In order to correctly evaluate and manage prostatic diseases, such as benign prostatic hypertrophy (BPH) and prostate cancer (PCa...

.... Holmium laser enucleation of the prostate Benign prostatic hyperplasia Transrectal prostate biopsy High-power holmium laser enucleation of the prostate Transurethral enucleation Holmium laser enucleation of the prostate (HoLEP) is the gold standard treatment for benign prostatic hyperplasia...

..., instructions or products referred to in the content or advertisements. Anticholinergics Benign prostatic hyperplasia Overactive Bladder Symptom Score Overactive bladder Subgroup analysis A 52-week course of tamsulosin + dutasteride + imidafenacin (TDI) triple therapy has been reported...

...Jian Zhang; Yonghui Wang; Shuang Li; Shipeng Jin; Shiqing Zhang; Chunli Zhao; Wenzeng Yang; Shujin Cui; Yuexin Liu Background: Benign prostatic hyperplasia (BPH) is a common chronic progressive disease resulting in urinary obstruction in aging men. It comes to more and more patients with massive...

... transplantation Vesicoureteral reflex Urological complications Allograft lithiasis Benign prostatic hyperplasia At present, kidney transplantation is undeniably the better option for the treatment of ESRD compared to dialysis. The 5-year survival rate with kidney transplantation, regardless of whether...

... and as surrogate markers for metabolic disease, cardiovascular disease, and malignancies, including prostate cancer. However, scant studies have investigated the association of NLR, PLR, and LMR with benign prostatic hyperplasia (BPH). Methods: Data from 8,727 middle-aged men who had participated in a health...

... records of patients with 80-g or larger prostates who underwent holmium laser enucleation of the prostate (HoLEP), laparoscopic simple prostatectomy (LSP), or open prostatectomy (OP) due to medical treatment-resistant benign prostatic hyperplasia (BPH) were reviewed retrospectively. Patients were...

...Ibrahim Karabulut; Ahmet Emre Cinislioglu; Nazan Cinislioglu; Fatih Kursat Yilmazel; Mustafa Utlu; Handan Alay; Erkan Cem Celik; Senol Adanur Purpose: To investigate the effectiveness of benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS), which occur as a natural result...

... of life (QoL) is still unknown. Objective: The effects of tadalafil on nocturia and nocturia-related QoL were evaluated prospectively in patients with benign prostatic hyperplasia (BPH) as a multicenter study. Methods: Eligible men were ≥40 years with nocturia ≥2 and a prostate volume ≥20 mL. Patients...